Similar articles for PMID: 26603745

Year	Number of Results
1918	1
1995	1
1998	2
2000	2
2002	2
2003	3
2004	1
2005	2
2006	4
2007	9
2008	3
2009	11
2010	14
2011	15
2012	15
2013	12
2014	14
2015	11
2016	9
2017	16
2018	16
2019	11
2020	15
2021	29
2022	13
2023	7
2024	0

1

Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).

Penaloza-Ramos MC, Jowett S, Mant J, Schwartz C, Bray EP, Sayeed Haque M, Richard Hobbs FD, Little P, Bryan S, Williams B, McManus RJ. Penaloza-Ramos MC, et al. Eur J Prev Cardiol. 2016 Jun;23(9):902-12. doi: 10.1177/2047487315618784. Epub 2015 Nov 24. Eur J Prev Cardiol. 2016. PMID: 26603745 Free article. Clinical Trial.

2

Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.

Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, Holder R, Jones MI, Little P, Williams B, McManus RJ. Kaambwa B, et al. Eur J Prev Cardiol. 2014 Dec;21(12):1517-30. doi: 10.1177/2047487313501886. Epub 2013 Aug 29. Eur J Prev Cardiol. 2014. PMID: 23990660 Clinical Trial.

3

Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4).

Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, Hobbs FDR, Hodgkinson J, Mant J, McManus RJ. Monahan M, et al. Hypertension. 2019 Jun;73(6):1231-1239. doi: 10.1161/HYPERTENSIONAHA.118.12415. Hypertension. 2019. PMID: 31067190 Free PMC article. Clinical Trial.

4

Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial.

O'Brien C, Bray EP, Bryan S, Greenfield SM, Haque MS, Hobbs FD, Jones MI, Jowett S, Kaambwa B, Little P, Mant J, Penaloza C, Schwartz C, Shackleford H, Varghese J, Williams B, McManus RJ. O'Brien C, et al. BMC Cardiovasc Disord. 2013 Mar 23;13:21. doi: 10.1186/1471-2261-13-21. BMC Cardiovasc Disord. 2013. PMID: 23522245 Free PMC article. Clinical Trial.

5

Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.

Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE. Moise N, et al. Hypertension. 2016 Jul;68(1):88-96. doi: 10.1161/HYPERTENSIONAHA.115.06814. Epub 2016 May 15. Hypertension. 2016. PMID: 27181996 Free PMC article.

6

The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension.

Peñaloza-Ramos MC, Jowett S, Sutton AJ, McManus RJ, Barton P. Peñaloza-Ramos MC, et al. Value Health. 2018 Mar;21(3):351-363. doi: 10.1016/j.jval.2017.03.003. Epub 2017 Oct 19. Value Health. 2018. PMID: 29566843 Free article.

7

The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.

Montgomery AA, Fahey T, Ben-Shlomo Y, Harding J. Montgomery AA, et al. J Hypertens. 2003 Sep;21(9):1753-9. doi: 10.1097/00004872-200309000-00026. J Hypertens. 2003. PMID: 12923409

8

Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.

Chowdhury EK, Reid CM, Zomer E, Kelly DJ, Liew D. Chowdhury EK, et al. Am J Hypertens. 2018 Sep 11;31(10):1156-1163. doi: 10.1093/ajh/hpy108. Am J Hypertens. 2018. PMID: 30010694

9

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.

Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, Tzong KY, Xiong J, Wang M, Zhao D, Goldman L, Moran AE. Gu D, et al. PLoS Med. 2015 Aug 4;12(8):e1001860. doi: 10.1371/journal.pmed.1001860. eCollection 2015 Aug. PLoS Med. 2015. PMID: 26241895 Free PMC article.

10

Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.

Constanti M, Floyd CN, Glover M, Boffa R, Wierzbicki AS, McManus RJ. Constanti M, et al. Hypertension. 2021 Feb;77(2):682-691. doi: 10.1161/HYPERTENSIONAHA.120.14913. Epub 2020 Dec 21. Hypertension. 2021. PMID: 33342242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

209 results

Results by year